MJBizDaily
Did the Trump administration approve cannabis interstate commerce?
Latest Posts
Report: Arkansas’ costs to legalize MMJ could outweigh tax revenue
Arkansas state finance officials said in a report released Thursday that legalizing medical marijuana would cost more to administer and enforce than the tax revenue it would generate, which could…
News October 21
Week in Review: Detroit crackdown, NYSE listing bid & LSU proposes big bucks on MMJ
By Bart Schaneman, Omar Sacirbey and John Schroyer Detroit cracks down on dispensaries, a cannabis real estate investment trust eyes a Big Board listing, and Louisiana State University proposes spending…
News October 21Prominent CA testing lab: 84% of marijuana samples contaminated
The cannabis industry still has a pesticide problem. Steep Hill, one of the leading names in cannabis testing, said in a press release Wednesday that a whopping 84% of marijuana…
News October 21Israeli pharmacies to start selling medical cannabis
Israeli pharmacies are gearing up to sell medical marijuana across the nation under the government’s ongoing efforts to liberalize the use and sale of MMJ. Super-Pharm, which has 225 branches…
News October 20Australian MMJ company lists stock, which soars
An Australian developer of marijuana-based medicines that debuted on the Australian Securities Exchange Thursday saw its stock soar 38% above its offering price before settling in to close 30% above…
News October 20
How the marijuana industry can keep its magic: Interview with Penn Jillette
By Bart Schaneman Penn Jillette is perhaps best known for the popular magic shows he’s been performing in Las Vegas with sidekick Teller for more than 20 years. But he’s also become a…
News October 20Polls: Marijuana legalization gaining steam nationally and in MA
Two new polls show cannabis gaining major ground with U.S. voters, with one finding that 60% of Americans want marijuana legalized and another discovering 55% support in Massachusetts for a ballot…
News October 20GW Pharma scuttles UK listing to trade on U.S. market
GW Pharmaceuticals, a high-flying biotech firm in the United Kingdom that is seeking U.S. regulatory approval for a CBD-based drug, has abandoned its U.K. stock market listing to instead trade…
News October 19Cannabis REIT files to be listed on NYSE
A cannabis-focused real estate investment trust has filed to list its shares on the New York Stock Exchange. If approved, it would be the first marijuana-related company to list on the Big…
News October 19
Latest Sponsored
